English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17775/20116 (88%)
Visitors : 10074688      Online Users : 611
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/27645


    標題: alpha-Lipoic acid prevents mild portal endotoxaemia-induced hepatic inflammation and beta cell dysfunction
    作者: Tian, Yu-Feng
    Hsieh, Chang-Hsun
    Hsieh, Yen-Ju
    Chen, Yu-Ting
    Peng, Yi-Jen
    Hsieh, Po-Shiuan
    貢獻者: 保健營養系
    關鍵字: A-Lipoic Acid
    Beta Cell Dysfunction
    Chronic Hepatic Inflammation
    Oxidative Stress
    Portal Endotoxaemia
    日期: 2012-06
    上傳時間: 2014-03-21 16:16:19 (UTC+8)
    出版者: Wiley-Blackwell
    摘要: Eur J Clin Invest 2012; 42 (6): 637648 Abstract Background This study was undertaken to evaluate the preventive effect of a-lipoic acid (LA) on chronic mild portal endotoxaemia-mediated subacute hepatic inflammation and pancreatic beta cell dysfunction in rats. Materials and methods Male SpragueDawley rats were randomly assigned into four groups: those with intraportal vehicle (saline) or low-dose lipopolysaccharide (LPS) (0.42 ng/kg/min) infusion, combined with oral administration of vehicle or LA, a potent antioxidant (60 mg/kg/day) for 4 weeks. The hyperglycaemic clamp and euglycaemic clamp techniques were used to access the glucose-stimulated insulin secretion and systemic insulin sensitivity in vivo. Results Body weight, fasting plasma glucose and insulin were not different among groups. In rats with chronic intraportal LPS infusion, plasma C-reactive protein, amylase, superoxide levels, the contents of thiobarbituric acid-reactive substance, tumour necrosis factor a and interleukin 6 in liver and pancreas and also the gene expression of Toll-like receptor 4 in liver were significantly increased as compared with those with LA cotreatment. The histopathological examination showed that inflammatory changes were clearly visible in liver and pancreatic islets of LPS-infused rats and rarely observed in those cotreated with LA. In addition, low-dose intraportal LPS infusion also significantly impaired glucose-stimulated insulin secretion but not affect the systemic insulin sensitivity and metabolic clearance rate of insulin. LA administration markedly reversed LPS-induced beta cell dysfunction. Conclusions a-Lipoic acid cotreatment could significantly prevent mild portal endotoxaemia-induced chronic hepatic inflammation and impaired pancreatic insulin secretion in absence of changing systemic insulin resistance.
    關聯: European Journal of Clinical Investigation, 42(6), 637-648
    Appears in Collections:[保健營養系(所) ] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML942View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback